Indolepyruvic acid
Alternative Names: Indole-3-pyruvic acid; IPALatest Information Update: 24 Oct 2021
At a glance
- Originator Polifarma
- Class Indoles; Small molecules
- Mechanism of Action Excitatory amino acid antagonists; Melanocortin receptor agonists; Melatonin receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Anxiety disorders; Major depressive disorder; Sleep disorders
Most Recent Events
- 23 Jul 2003 No development reported - Phase-II for Anxiety disorders in Italy (PO)
- 23 Jul 2003 No development reported - Phase-II for Depression in Italy (PO)
- 23 Jul 2003 No development reported - Phase-II for Sleep disorders in Italy (PO)